Medesis Pharma wishes to accelerate the development of its antinuclear products and provides an update on its strategy
Medesis Pharma wishes to accelerate the development of its antinuclear products and provides an update…
Medesis Pharma wishes to accelerate the development of its antinuclear products and provides an update…
Phase 1a dose escalation of ART0380 defined initial regimen to be evaluated in Phase 1b…
Clearance of critical milestone expands capability for production of gene therapies, starting with Zolgensma® Basel,…
Figure 1 Kaplan Meier – Preliminary survival rate analysis of Roll-In Cohort, dated 25 March…
ST. LOUIS, April 05, 2022 (GLOBE NEWSWIRE) — Curium announced today that its generic version…
Interim data suggest long-term treatment with VYVGART provides improvement in generalized myasthenia gravis (gMG)…
Pilot aims to streamline handoff from warehouse inventory robots to picking robots so that businesses…
JAKARTA, Indonesia–(BUSINESS WIRE)–PT Freeport Indonesia (“PT-FI” or the “Company”) announced today that it intends to…
Acquisition Brings Advanced, AI powered Omnichannel Conversational Engagement Solutions to BFSI Organizations SAN FRANCISCO &…
Tony Fadell’s Future Shape also joins Series B round Company has raised $100 million in…
ZURICH, SWITZERLAND, Apr 5, 2022 – (JCN Newswire) – Hitachi Energy today launched its OceaniQ…
TOKYO, Apr 5, 2022 – (JCN Newswire) – Fujitsu today announced the development and deployment…
TOKYO, Apr 5, 2022 – (JCN Newswire) – NTT DOCOMO, INC. announced today that it…
Speeds of over 1 Gbps in 5G Non-Standalone configuration validating the growing maturity of Open…
FORT WORTH, TX, April 04, 2022 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara,” the “Company,”…
Singapore, Apr 5, 2022 – (ACN Newswire) – 2022 continues to be a challenging year…
NEW YORK–(BUSINESS WIRE)–Labaton Sucharow LLP (“Labaton Sucharow”) announces that on April 4, 2022, it filed…
By Dr. Shaun Passley In terms of sheer versatility, it’s hard to imagine an invention…
GAINESVILLE, Fla., and CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC),…
Annual Report on Form 10-K for fiscal year ended December 31, 2021 to be filed…